e-learning
resources
London 2016
Wednesday, 07.09.2016
Management of dyspnoea and exacerbations in chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prescription of opioids for breathlessness in end-stage chronic obstructive pulmonary disease: A national population based study
Zainab Ahmadi (Lund, Sweden), Zainab Ahmadi, Eva Bernelid, David C. Currow, Magnus P. Ekström
Source:
International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Session:
Management of dyspnoea and exacerbations in chronic lung diseases
Session type:
Oral Presentation
Number:
4811
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Zainab Ahmadi (Lund, Sweden), Zainab Ahmadi, Eva Bernelid, David C. Currow, Magnus P. Ekström. Prescription of opioids for breathlessness in end-stage chronic obstructive pulmonary disease: A national population based study. Eur Respir J 2016; 48: Suppl. 60, 4811
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
A pilot study to assess the efficacy of breathlessness plans for patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Dietary habits in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013
Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Secondary prevention of osteoporosis (OP) in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015
The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014
Clinical characteristics and health burden of patients with chronic obstructive pulmonary disease exacerbation
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015
Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
Dyspnoea management in end-stage lung disease
Source: Annual Congress 2006 - Improving end-of-life care
Year: 2006
Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Postural abnormalities in people with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease
Year: 2016
Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Proactive integrated care improves quality of life in patients with COPD
Source: Eur Respir J 2009; 33: 1031-1038
Year: 2009
Nutritional status in chronic obstructive pulmonary disease
Source: International Congress 2014 – Comorbidities
Year: 2014
Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Drug prescribing and burden of asthma and chronic obstructive pulmonary disease (COPD): a study from Italian general practitioners
Source: Eur Respir J 2005; 26: Suppl. 49, 672s
Year: 2005
Obesity and impairments in chronic obstruction pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Socioeconomic burden of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=463
Year: 2006
Comorbidities in chronic obstructive pulmonary disease - Results of a national multicenter research project
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept